logo
Five new dogs bring smiles to people with expansion of company's CareBark service

Five new dogs bring smiles to people with expansion of company's CareBark service

Yahoo29-04-2025
Homecare company Caremark Redcar and Cleveland has expanded its animal-assisted therapy service, CareBark, with the addition of five dogs.
This brings the total number of CareBark dogs to ten.
The new recruits, Shadow, Kyro, and Wren (all Labradors), Blue (Cockapoo), and Marley (Labradoodle), join the existing team of Labradors - Red, Chance, Emmie, and Axel, and Cockapoo Wilma.
The dogs and their seven human handlers visit customers' homes across the Redcar and Cleveland area, and are integrated into customers' assessed need care packages.
The dogs support customers with mental health and wellbeing, prevent loneliness, and provide motivation to get them moving and into the community.
The service also works with schools, colleges, day centres, care homes, and Caremark's Safe Place activity-led day centre, in Redcar.
Caremark Redcar and Cleveland managing director Michelle Jackson, who owns the dogs and established the service, said: "We only set up the service in 2023 and have been overwhelmed by the positive response to the dogs and to see the major impact they are having on people's lives across our area.
"We are achieving some amazing outcomes for people.
"The dogs have helped people leave their houses for the first time in years, brought joy to children with life-limiting conditions, and are helping people to meet new friends through their shared interests and love of a dog."
One organisation that benefits from regular contact with the dogs is Prior Pursglove College, in Guisborough.
Students with special educational needs in the Endeavour Faculty at the college participated in a fundraising event which helped to pay for sessions with the dogs.
One of the students, Hamza, said: "I am very scared of dogs so I kept my distance initially but once I got to know them, especially Kyro, I was fine and really enjoyed being with them."
Another student, Rob, said: "We were able to take the dogs outside and play with them, which was great."
Prior Pursglove tutor Helen Beadnall said: "When the dogs were here everyone was smiling and wanted to come over to them.
"It got the students very relaxed and focused and it brought them lots of joy.
"We have one young man who has difficulty regulating his emotions and can use inappropriate language, but when he was with the dogs, he didn't swear once and we saw the very best side of his personality, which was wonderful to witness."
READ MORE:
Lasting legacy created to honour the Sycamore Gap tree | The Northern Echo
Person airlifted to hospital after falling from Roseberry Topping | The Northern Echo
Postcode Lottery won in Crook, Hartlepool and Sunderland | The Northern Echo
The CareBark service is a chargeable service due to Caremark employing the dog handlers and not relying on volunteers.
The service can be contracted via Redcar and Cleveland Council as part of an assessed need, or paid for privately for anyone else wishing to use the service.
People in the community who are interested in the dogs coming to their home, care home, day centre, or any other venue can contact Caremark on 01287 634706 or email redcar@caremark.co.uk.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Saddam Hossain Roni: The Youth Leader Behind Bangladesh's First 24/7 Suicide Prevention Platform
Saddam Hossain Roni: The Youth Leader Behind Bangladesh's First 24/7 Suicide Prevention Platform

Time Business News

time6 hours ago

  • Time Business News

Saddam Hossain Roni: The Youth Leader Behind Bangladesh's First 24/7 Suicide Prevention Platform

Dhaka, July 2025 – In a country where mental health still carries immense stigma and professional support remains largely inaccessible, Md. Saddam Hossain Roni is emerging as a symbol of change. At just 31, he is the Founder of Talk Hope, Bangladesh's first 24/7 youth-led suicide prevention and emotional support platform — a movement driven by empathy, technology, and community. 🎓 A Humble Beginning to a Life of Purpose Born on 7 May 1994 in Feni, Bangladesh, Roni completed his SSC and HSC from Cumilla, and went on to earn his Bachelor's in Electrical and Electronic Engineering (EEE) from American International University-Bangladesh (AIUB). His passion for youth leadership was cultivated early through years of involvement in Rotaract, Leo Club, and national volunteering networks. 🧠 Talk Hope: A Lifeline Born from Listening In February 2024, Roni launched Talk Hope, a non-profit emotional support service that connects trained youth volunteers and psychologists with individuals experiencing distress, anxiety, and suicidal ideation. Over 200+ trained volunteers have been mobilized to offer 24/7 support. On SSC result day 2025 alone, 20+ suicide interventions were successfully made. Services include WhatsApp helplines, PFA-based peer support, and mental health workshops in schools and universities. Recognized by Dhaka Tribune as 'Bangladesh's first youth-led 24/7 suicide prevention service.' 'We are not professionals. But we are listeners. And sometimes, a listener is all a person needs to survive.' – Roni 🌐 Founder of SHADOW – Building Systems That Empower Alongside Talk Hope, Roni is the Founder & Executive Director of SHADOW (Society for Humanity and Development Over the World), a youth-led social impact organization that works on: Disaster response and climate resilience Public sanitation campaigns Empathy-based education Digital awareness and mental health He designed and led Empathy 2023, a mental health-themed rock concert that gathered over 12,000 youth in Dhaka. 🏢 Professional Roles & Business Ventures Roni has successfully combined his engineering knowledge with his passion for service to become a multi-sector entrepreneur. He currently serves as: Founder & CEO – SHADOW IT Managing Director (MD) – SHADOW Communications Managing Director (MD) – SHADOW Engineering Solutions Founder & Executive Director – SHADOW (NGO) Founder & Chief Coordinator – Talk Hope Each wing focuses on community-driven development while offering youth employment and training opportunities in: Cybersecurity Web & mobile app development Educational tools and mental health tech Event production and strategic communication 🎓 Certifications & Global Training Roni has received training from prestigious global institutions: Psychological First Aid – Johns Hopkins University Google IT Support Specialist – Google Youth Suicide Prevention Training – Mindframe Australia IBM Data Science Professional Certificate – IBM Climate Change and Youth Resilience – UNDP Asia-Pacific He regularly writes about mental health and youth empowerment on Medium and LinkedIn, where his work has inspired thousands of readers. 🏅 Awards & Recognition Named in Top 5 Rotaract All-Stars (2017) Featured in Dhaka Tribune, Bangla Tribune, Daily Sun, Channel 24, LCIF Pride, and more Honored by youth networks and NGOs for contributions to suicide prevention Invited to represent Bangladesh at international youth forums and summits 🔮 Vision: A Bangladesh Where Youth Don't Suffer in Silence Roni's initiatives aim to: Embed mental health education into schools and universities Train 10,000+ first responders across Bangladesh by 2030 Establish a nationwide, free mental health support system using both online and offline models Create scalable tech-driven solutions for empathy-based community care 'Mental health support should not be a luxury. It must be a basic human right, especially for the youth who will shape tomorrow's world.' Summary Table Category Information Full Name Md. Saddam Hossain RoniDate of Birth 7 May 1994Origin Feni, BangladeshEducation BSc in Electrical & Electronic Engineering, AIUBMain Initiative Founder & Chief Coordinator – Talk HopeNGO Leadership Founder & Executive Director – SHADOWBusiness Titles CEO – SHADOW ITMD – SHADOW CommunicationsMD – SHADOW Engineering SolutionsFocus Areas Suicide Prevention, Mental Health Advocacy, Youth Empowerment, Tech for GoodGlobal Training Johns Hopkins, Google, IBM, UNDP, Mindframe Recognition Rotaract All-Star, Multiple National Media Features

CVS Beats Out UnitedHealth for Calpers Pharmacy Benefits Deal
CVS Beats Out UnitedHealth for Calpers Pharmacy Benefits Deal

Wall Street Journal

time16-07-2025

  • Wall Street Journal

CVS Beats Out UnitedHealth for Calpers Pharmacy Benefits Deal

CVS Health's CVS -0.65%decrease; red down pointing triangle Caremark business signed a new pharmacy benefits contract with the California Public Employees' Retirement System, known as Calpers. The five-year contract provides outpatient drug benefits for about 587,000 Calpers members, which represents roughly 40% of its clients that receive healthcare benefits. CVS will begin providing benefits starting on Jan. 1.

CVS dropped Zepbound in standard coverage. What that means for Zepbound users
CVS dropped Zepbound in standard coverage. What that means for Zepbound users

Indianapolis Star

time07-07-2025

  • Indianapolis Star

CVS dropped Zepbound in standard coverage. What that means for Zepbound users

When Zepbound, Eli Lilly's highly anticipated weight loss drug, hit the market a year and a half ago, it marked a turning point for the accessibility of weight loss drugs. Since then, Zepbound, the brand name for tirzepatide, has nearly become a household drug brand. Lilly estimates 4.5 million people take one of the Indianapolis drugmaker's GLP-1 medicines to lose weight or curb other health concerns like sleep apnea. But a recent coverage change by a major pharmacy benefit manager may force many to decide how much they're willing to pay for the drug or whether they want to try another weight loss option. As of July 1, CVS dropped Zepbound from preferred coverage for those covered by its pharmacy benefit manager, Caremark. Novo Nordisk A/S's Wegovy, a semiglutide injectable medicine, is now the primary weight loss drug offered on CVS's standard formulary, a list of medications an insurance plan covers. The news was not only a blow to Lilly but also a surprise to millions using Zepbound on Caremark plans, who are now questioning how to move forward. Here's what to know if you are affected by the CVS Caremark formulary change. First, check your mailbox. Those affected should have received a letter with additional information and next steps that could vary person to person. Generally speaking, under the formulary change, CVS Caremark will now cover Wegovy for patients prescribed GLP-1 drugs, and patients on Caremark insurance plans should be able to switch easily. Those who currently use Zepbound on an insurance plan negotiated by Caremark should have received a letter stating the date their transition goes into effect. Some transitions may happen later than July 1, depending on the plan's sponsor. The coverage change only applies to employer and union insurance plans that choose the standard formulary template, about one-third of the population Caremark covers. Those using weight loss drugs on coverage plans different from the standard formulary are not impacted. Talk to your doctor if you have concerns about switching. Caremark offers a medical exceptions process for patients to gain access to off-formulary medications if the preferred alternative is ineffective. Or, talk to your employer. Some employers negotiate their own coverage plans so they may be able to switch to a non-standard formulary. Lilly also offers resources online to those on Zepbound. The list price for Zepbound sits at $1,086 for a 28-day supply, for those without insurance. Lilly estimates patients who have insurance that covers Zepbound pay as little as $25 for a one or three-month supply. Those with commercial insurance plans that do not cover Zepbound may be eligible for a 1-month supply that runs $650. One month equates to 28 days, or four injectable pens. Yes. Lilly sells vials of Zepbound to consumers through its online sales portal, LillyDirect. The lowest dose of 2.5 milligrams starts at $349 for four single doses that will last four weeks. Higher dose packs start at $499. The Indianapolis drugmaker expanded access through LillyDirect, and providers will be able to prescribe 12.5 and 15 milligram doses starting July 7. CVS Caremark estimates between 25 to 30 million people use its standard formulary template, comprising about 30% of its entire membership base. However, not all of those members take weight loss drugs. Weight loss drugs represent about 10% of what Caremark clients spend, up from 1% just a couple of years ago, a CVS executive said. Wegovy and Zepbound use is pretty evenly split for those on weight loss drugs through Caremark plans. Not entirely. Zepbound and Wegovy come from the same class of GLP-1 drugs and deliver significant weight loss through a once-weekly injection. But the two medications have different main active ingredients. Zepbound's main ingredient is tirzepatide and is approved for weight loss and obstructive sleep apnea. Wegovy is a semiglutide medication and helps manage weight loss and cardiovascular health. Though the two drugs are both approved for weight loss, a study published in May funded by Eli Lilly found that patients on Zepbound were more likely to experience weight loss. It was the first time the drugs were compared head-to-head. Caremark says it is dropping Zepbound from preferred coverage to ultimately lower the cost of the drug for its clients. Since Wegovy and Zepbound are clinically similar products approved for weight loss, Caremark encourages the drug manufacturers to compete against each other for preferred insurance coverage for millions of patients. Doing so, Caremark says, can significantly lower prices for employers and unions. "Our decision to prefer Wegovy over Zepbound will deliver significant cost savings for our clients in this therapy class, and the lower net price we were able to negotiate for Wegovy will enable more employers to provide coverage for the weight loss category," CVS Health Vice President of External Affairs David Whitrap told IndyStar in a written statement. Caremark expects employers and unions to expand access to Wegovy as a result of the change in policy. Two other GLP-1 injectables exist on the market, though each varies slightly from Zepbound and Wegovy. Ozempic, the original blockbuster semaglutide injection developed by Novo Nordisk, is used to treat type 2 diabetes. Mounjaro, a Lilly tirzepatide drug, is approved to treat type 2 diabetes when combined with diet and exercise. Eli Lilly is also well into clinical trials for the development of orforglipron, an oral GLP-1 drug for type 2 diabetes and weight management.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store